| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Chadwick Jeremy G is a Chief Operating Officer at KYMR. Recent filings cover 0 purchases and 33 sales. Those positions are worth an estimated $3.6M at current prices.
Our model assigns Chadwick Jeremy G a below-average insider score of 33/100, based on 6 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -62.0%.
Chadwick Jeremy G's largest disclosed position is in KYMR as Chief Operating Officer, worth about $3.6M. The recent filings there lean toward selling, a net 200,501 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2026 | KYMR Kymera Therapeutics, Inc. | Chief Operating Officer | Sell | 17,184 | $79.92 | $1,373,289.53 | -28.1% | - | - | |
| Apr 22, 2026 | KYMR Kymera Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 300 | $90.00 | $27,000.00 | -0.5% | - | - | |
| Apr 15, 2026 | KYMR Kymera Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 6,551 | $90.00 | $589,598.40 | -9.7% | +25.9% | - | |
| Apr 1, 2026 | KYMR Kymera Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 22,240 | $85.43 | $1,900,047.90 | -26.7% | - | - | |
| Mar 25, 2026 | KYMR Kymera Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 115,977 | $78.02 | $9,048,290.11 | -65.5% | - | - | |
| Mar 11, 2026 | KYMR Kymera Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 25,758 | $83.30 | $2,145,673.35 | -27.5% | -5.7% | - | |
| Mar 4, 2026 | KYMR Kymera Therapeutics, Inc. | Chief Operating Officer | Sell | 5,958 | $86.54 | $515,594.13 | -7.5% | - | - | |
| May 23, 2025 | KYMR Kymera Therapeutics, Inc. | Chief Operating Officer | Sell | 2,575 | $29.30 | $75,435.66 | -3.7% | +44.4% | +167.5% | |
| Mar 3, 2025 | KYMR Kymera Therapeutics, Inc. | Chief Operating Officer | Sell | 1,383 | $30.45 | $42,113.11 | -2.0% | +43.0% | +186.3% | |
| May 23, 2024 | KYMR Kymera Therapeutics, Inc. | Chief Operating Officer | Sell | 2,575 | $34.99 | $90,104.66 | -5.5% | +41.8% | -13.9% |